The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReneuron Share News (RENE)

  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: ReNeuron warns; Gama Aviation pledges cash return

Mon, 05th Feb 2024 20:23

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

----------

ReNeuron Group PLC - Brigdend, Wales-based stem cell and exosomes technology company - Requests suspension of trading in company's shares. Warns company is in a highly constrained financial position and requires additional financing urgently, in order to continue as a going concern. Continues to explore a number of corporate options, including seeking to realise value for its physical and intellectual assets, but recognises that in the absence of an immediate injection of capital it needs to put staff at risk of redundancy, initiate discussions with its creditors and establish the precise solvency status of the business. Explains should it fail to achieve a solution in the short term, the board would have no option but to place the company into administration.

----------

Gama Aviation PLC - Farnborough, England-based aviation services company - Expects revenue from continuing operations for 2023 of around USD145 million, down from USD168 million in 2022. Predicts adjusted earnings before interest and tax broadly in line with expectations, despite some variances in performance across the business units. Ends year with net cash of USD82 million. Intends to make GBP16.5 million return to shareholders by a tender offer at 95 pence per share as part of a phased cash return.

----------

CEPS PLC - Bath, England-based investment company focussed on industrial sector - Reports trading for 2023 is in line with expectations which would be record results. Adds, all segments have made a solid start to 2024. Expects surplus from wound up pension scheme to total GBP537,086. Estimates receipts, net of tax will be GBP402,815, which will be received in April. Explains this will have a positive impact on the profit and loss account and balance sheet as the surplus on the scheme has not been recognised in the company's accounts. Further, plans to seek approval at a General Meeting for a share capital reduction. In addition, company is considering a recent and alleged claim from a former landlord for dilapidations and CEPS is liaising with its advisers on what it considers to be a more realistic assessment of the liability and quantum, if any.

----------

Sondrel Holdings PLC - Reading, England-based semiconductor design services provider - Confirms receipt of GBP1.5 million of payments in relation to the material turnkey application-specific integrated circuit engagement with an automotive Tier 1 supplier. Says talks with the customer over resolution of the funding for the project extension continue and additional payments are expected in the coming months, assuming completion of the 'tape out' milestone and including the balance of GBP0.2 million. Significant new ASIC business opportunities are in final negotiation for project start in early 2024 and indications remain encouraging that European and US market demand for Sondrel's turnkey ASIC services is strong, company says. Talks ongoing with suppliers to improve the terms of existing supply arrangements. Continues to seek additional capital prior to the end of March 2024 to meet short-term working capital requirements.

----------

Upland Resources Ltd - London-based oil and gas company, which has assets in Malaysia, Tunisia and the UK North Sea - Updates in relation to the Sarawak Block SK334 exploration campaign. Explains pre-drill activities have been identified and a pre-drill work program has been developed to allow early commencement of activities and expedite the drilling program.

----------

Gore Street Energy Storage Fund PLC - investor in utility-scale energy storage projects - Trading update. Reaffirms dividend target of 7% of net asset value for the financial year. Maintains a healthy balance sheet with low debt. At December 31, had GBP66 million in cash or cash equivalents. Operational fleet is on track to more than double by the end of 2024, company says.

----------

Clontarf Energy PLC - lithium and oil gas exploration and production company focused on South American and Africa - Notes the Bolivian State Lithium Co formally launched, on January 26, its second Call for Bids over seven priority salares (salt pans) in Potosi y Oruro. This includes scope for direct lithium extraction proposals and will provide a firm legal basis for work, under Bolivian laws. Says Clontarf has been encouraged to submit bids on further development of the key Uyuni, Coipasa, Pastos Grandes, Capina, Cañapa, Chiguana and Empexa salares. Further, actively participating in the priority European Union lithium initiative. This included a EU delegation to Bolivia and Argentina during November and December 2023, which included several site visits.

----------

Trident Royalties PLC - mining royalty and streaming, providing investment exposure to base, battery, precious and bulk metals - Reports quarterly receipts of USD3.2 million from exposure to gold, copper, and iron ore, a 63% increase from the third quarter, driven principally by seasonally higher deliveries from the gold off-take portfolio. Excluding the Mimbula copper royalty, receipts were slightly above the fourth quarter 2022. Says net debt at December 31 was USD22 million.

----------

Ethernity Networks Ltd - Israel-based supplier of data processing semiconductor technology for networking appliances - Further to announcement on January 31, reports the Court in Lod approved, on February 4, the proposed creditor settlement plan, details of which were announced on January 11. Following this approval, the company can now continue to undertake its business and operations as usual.

----------

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
12 Aug 2020 13:35

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

IN BRIEF: ReNeuron Adds Obotritia Rep To Board; Names New Chair

Read more
31 Jul 2020 16:22

ReNeuron gets patent allowance in the US

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Friday that the US Patent and Trademark office (USPTO) has completed its examination of its application titled 'phenotype profile of human retinal progenitor cells', and has issued a notification of allowance for the issue of a patent.

Read more
31 Jul 2020 11:28

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

UK WINNERS & LOSERS SUMMARY: Pets At Home Up 15% On June Sales Bounce

Read more
29 Jun 2020 20:39

IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment

IN BRIEF: ReNeuron Posts Encouraging Data On Eye Condition Treatment

Read more
25 Jun 2020 14:55

IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm

IN BRIEF: ReNeuron Signs Exosome Research Collaboration With US Firm

Read more
25 Jun 2020 11:22

ReNeuron Group inks research evaluation deal with US firm

(Sharecast News) - Cell-based therapeutics company ReNeuron Group announced on Thursday that it has signed a new research evaluation agreement with a major United States biotechnology company, in connection with the use of its proprietary exosomes for the delivery of novel gene silencing therapeutics.

Read more
17 Jun 2020 15:58

IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial

IN BRIEF: ReNeuron Gets Approval In US And UK For Expanded Drug Trial

Read more
3 Apr 2020 11:41

UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On

UK TRADING UPDATE SUMMARY: Bagir Says Cash Insufficient To Carry On

Read more
24 Feb 2020 12:24

Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study

Positive hRPC Stem Cell Trial Data Prompts ReNeuron To Expand Study

Read more
17 Feb 2020 10:29

Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal

Data From ReNeuron CTX Stem Cell Therapy Trial Published In Journal

Read more
18 Dec 2019 19:08

Woodford Transfers Series Of Holdings To New Manager Schroders

Woodford Transfers Series Of Holdings To New Manager Schroders

Read more
6 Dec 2019 10:42

ReNeuron cuts losses after Fosun licence payment

(Sharecast News) - ReNeuron Group on Friday reported a narrower interim loss after receiving payment from a Chinese licensee, while it also made progress in its clinical and research programmes.

Read more
6 Dec 2019 09:32

ReNeuron Reports "Strong Progress" Across Various Programmes

ReNeuron Reports "Strong Progress" Across Various Programmes

Read more
29 Nov 2019 16:07

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
23 Oct 2019 15:50

ReNeuron presents new data on CTX stem cell platform

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced on Wednesday that new data relating to its CTX stem cell platform was being presented at the 27th Annual Congress of the European Society of Gene and Cell Therapy in Barcelona.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.